Caption Management, LLC Halozyme Therapeutics, Inc. Call Options Transaction History

Caption Management, LLC

11 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 15, 2022	SELL	$37.35 - $48.3 $1.93 Million - $2.5 Million	-51,800 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$31.97 - $41.06 $1.66 Million - $2.13 Million	51,800 New	51,800 $2.07 Million
Q3 2021 Nov 12, 2021	SELL	$38.47 - $46.42 $1.54 Million - $1.86 Million	-40,000 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$38.84 - $51.31 $815,640 - $1.08 Million	-21,000 Reduced 34.43%	40,000 $1.82 Million
Q1 2021 May 17, 2021	BUY	$39.51 - $51.45 $2.41 Million - $3.14 Million	61,000 New	61,000 $2.54 Million
Q2 2020 Aug 14, 2020	SELL	$16.25 - $26.81 $975,000 - $1.61 Million	-60,000 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$13.9 - $21.83 $1.18 Million - $1.86 Million	-85,000 Reduced 58.62%	60,000 $1.08 Million
Q4 2019 Feb 13, 2020	BUY	$14.93 - $19.53 $1.12 Million - $1.46 Million	75,000 Added 107.14%	145,000 $2.57 Million
Q3 2019 Nov 14, 2019	BUY	$15.2 - $17.69 $608,000 - $707,600	40,000 Added 133.33%	70,000 $1.09 Million
Q2 2019 Aug 13, 2019	SELL	$14.75 - $17.26 $7.46 Million - $8.72 Million	-505,500 Reduced 94.4%	30,000 $516,000
Q4 2017 Feb 14, 2018	BUY	$16.75 - $20.8 $8.97 Million - $11.1 Million	535,500	535,500 $10.8 Million

543

125M

294K

180K

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.57B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.